Sign in
4

Changes in Ownership

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000099

Chief Executive Officer acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Emerson Erik C. Chief Executive Officer 2025-05-16 Grant or award +750,000 750,000 D
Derivatives
Emerson Erik C. Chief Executive Officer 2025-05-16 Grant or award · Stock option (right to buy) +347,279 347,279 D
Loading xslF345X05/primary_doc.xml…